학술논문

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations.
Document Type
Article
Source
Investigational New Drugs; Jun2015, Vol. 33 Issue 3, p740-750, 11p
Subject
PROTEIN kinase inhibitors
ACADEMIC medical centers
ANALYSIS of covariance
ANTINEOPLASTIC agents
BLOOD testing
COLON tumors
CONFIDENCE intervals
METASTASIS
PLACEBOS
QUESTIONNAIRES
RECTUM tumors
REGRESSION analysis
RESEARCH funding
SAFETY
STATISTICS
WORLD health
DATA analysis
RANDOMIZED controlled trials
VISUAL analog scale
TREATMENT effectiveness
PROPORTIONAL hazards models
BLIND experiment
DESCRIPTIVE statistics
KAPLAN-Meier estimator
PHARMACODYNAMICS
THERAPEUTICS
Language
ISSN
01676997
Abstract
Copyright of Investigational New Drugs is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)